21 CFR Part 216 - HUMAN DRUG COMPOUNDING

Authority:
21 U.S.C. 351, 352, 353a, 353b, 355, and 371.
Source:
64 FR 10944, Mar. 8, 1999, unless otherwise noted.
{'United States Code': [{'Title': '21', 'Section': '351', 'headtext': ' Adulterated drugs and devices', 'cleanpath': '/uscode/text/21/351'}, {'Title': '21', 'Section': '352', 'headtext': ' Misbranded drugs and devices', 'cleanpath': '/uscode/text/21/352'}, {'Title': '21', 'Section': '353a', 'headtext': ' Pharmacy compounding', 'cleanpath': '/uscode/text/21/353a'}, {'Title': '21', 'Section': '353b', 'headtext': ' Outsourcing facilities', 'cleanpath': '/uscode/text/21/353b'}, {'Title': '21', 'Section': '355', 'headtext': ' New drugs', 'cleanpath': '/uscode/text/21/355'}, {'Title': '21', 'Section': '371', 'headtext': ' Regulations and hearings', 'cleanpath': '/uscode/text/21/371'}], 'Statutes at Large': [], 'Public Laws': [], 'Presidential Documents': []}